Rationale, design and baseline characteristics of a large, simple, randomized trial of combined folic acid and vitamins B6 and B12 in high-risk patients: the Heart Outcomes Prevention Evaluation (HOPE)-2 trial.

Elsevier, Canadian Journal of Cardiology, 1(22), p. 47-53

Journal article published in 2006 by J. Probstfield, M. McQueen, M. Micks, J. Pogue, P. Sheridan, S. Yusuf, C. Held, J. M. O. Arnold, J. Bosch

, Eva Lonn, J. Genest

This paper is available in a repository.

Full text: Download

Preprint: archiving allowed

Upload

Postprint: archiving restricted

Upload

Published version: archiving forbidden

Policy details

Data provided by